Genmab A/S (GMAB)
34.74
+0.20
(+0.59%)
USD |
NASDAQ |
Sep 18, 16:00
34.74
0.00 (0.00%)
After-Hours: 20:00
Genmab Cash from Operations (Quarterly) : 51.04M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.04M |
| March 31, 2026 | 3.011M |
| December 31, 2025 | 301.02M |
| September 30, 2025 | 536.82M |
| June 30, 2025 | 64.59M |
| March 31, 2025 | 287.20M |
| December 31, 2024 | 398.22M |
| September 30, 2024 | 296.64M |
| June 30, 2024 | 218.00M |
| March 31, 2024 | 220.25M |
| December 31, 2023 | 229.94M |
| September 30, 2023 | 299.71M |
| June 30, 2023 | 67.84M |
| March 31, 2023 | 466.33M |
| December 31, 2022 | 45.00M |
| September 30, 2022 | 275.29M |
| June 30, 2022 | 139.11M |
| March 31, 2022 | 88.50M |
| December 31, 2021 | 34.60M |
| September 30, 2021 | 92.21M |
| June 30, 2021 | 35.76M |
| March 31, 2021 | 191.92M |
| December 31, 2020 | -95.48M |
| September 30, 2020 | 767.49M |
| June 30, 2020 | -6.871M |
| Date | Value |
|---|---|
| March 31, 2020 | 323.21M |
| December 31, 2019 | 23.14M |
| September 30, 2019 | 49.90M |
| June 30, 2019 | 27.42M |
| March 31, 2019 | 97.13M |
| December 31, 2018 | 31.62M |
| September 30, 2018 | 31.72M |
| June 30, 2018 | 21.23M |
| March 31, 2018 | 76.59M |
| December 31, 2017 | 40.89M |
| September 30, 2017 | 12.88M |
| June 30, 2017 | 80.10M |
| March 31, 2017 | 107.79M |
| December 31, 2016 | -11.74M |
| September 30, 2016 | 30.41M |
| June 30, 2016 | 31.51M |
| March 31, 2016 | -1.276M |
| December 31, 2015 | 37.71M |
| September 30, 2015 | 20.50M |
| June 30, 2015 | -3.258M |
| March 31, 2015 | -8.360M |
| December 31, 2014 | 1.254M |
| September 30, 2014 | 16.71M |
| June 30, 2014 | 9.535M |
| March 31, 2014 | -3.734M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| AbbVie, Inc. | 3.436B |
| Ascendis Pharma A/S | 327.52M |
| Zealand Pharma A/S | 63.85M |
| Bavarian Nordic A/S | 55.02M |
| Evaxion AS | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.026M |
| Cash from Financing (Quarterly) | -74.60M |
| Free Cash Flow | 869.04M |
| Free Cash Flow Per Share (Quarterly) | 0.0779 |
| Free Cash Flow to Equity (Quarterly) | 126.04M |
| Free Cash Flow to Firm (Quarterly) | 160.88M |
| Free Cash Flow Yield | 3.93% |